HEMOFARM AКCIONARSKO DRUŠTVO FARMACEUTSKO-HEMIJSKA INDUSTRIJA VRŠAC
Acronym: HEMOFARM AD
General Information
Identification Code: 279842953110-22
Website: https://www.hemofarm.com/
Entity Form: joint venture company
Registration Category: Companies & groups
Registration Date: 3/4/2024
Mission & Interests
Goals: Hemofarm A.D., established in Vršac, Serbia, in 1960, has evolved into the region's premier generic pharmaceutical entity. As a subsidiary of the global STADA Group since 2006, it underscores a commitment to crafting accessible, high-quality medications, marking its leadership in Serbia's pharmaceutical landscape by commanding over 70% of the nation's drug exports. With a robust workforce and a significant production increase in 2023, Hemofarm stands at the forefront of addressing healthcare needs. The company focuses on a three-pillar strategy consisting of consumer healthcare products, generics and specialty pharma.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Business and industry
- Environment
- Public health
- Trade
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: Union List of Critical Medicines (https://www.ema.europa.eu/en/news/first-version-union-list-critical-medicines-agreed-help-avoid-potential-shortages-eu)
Proposal for a Regulation laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency (https://eur-lex.europa.eu/resource.html?uri=cellar:e3f40e76-e437-11ed-a05c-01aa75ed71a1.0001.02/DOC_1&format=PDF)
Communication from the Commission – Addressing medicines shortages in the EU (https://commission.europa.eu/system/files/2023-10/Communication_medicines_shortages_EN_0.pdf)
Commission proposal for the Pharmaceutical Regulation (https://health.ec.europa.eu/publications/proposal-regulation-laying-down-union-procedures-authorisation-and-supervision-medicinal-products_en)
Commission proposal for the Pharmaceutical Directive (https://health.ec.europa.eu/publications/proposal-directive-union-code-relating-medicinal-products-human-use_en)
Communication Activities: Supporting Medicines for Europe outreach on medicines access
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: Beogradski put BBHemofarm AD
Post Code: 11000
City: Vrsac
Country: SERBIA
Phone:
Indic Phone: 381
Phone Number: 648794853
EU Office
Address: Prote Mateje 70AHemofarm AD
Post Code: 11000
City: Beograd
Country: SERBIA
Phone:
Indic Phone: 381
Phone Number: 648794853
Financial Data
Closed Year:
Start Date:
End Date:
Funding Sources:
Contributions:
Total Budget: 0
Grants:
Current Year:
Grants:
Membership Information
Members10 Percent: 1
Members: 1
Members F T E: 0.10000000149011612
Structure
Structure Type: Structure
Is Member Of: Hemofarm AD is a corporate organization with a single shareholder. We do not have members, the list of all our corporate affiliates is visible at the corporate website (https://www.hemofarm.com/srb/predstavnistva).
Organisation Members: Hemofarm as a legal person is member of:
Chamber of Commerce in Serbia- https://pks.rs/
American Chamber of Commerce in Serbia- https://amcham.rs/
Foreign Investors Council- https://fic.org.rs/
German-Serbian Chamber of Commerce- https://serbien.ahk.de/sr/
Corporate Compliance Association- https://www.cca.rs/en/
Legal Council Association- https://www.ukp.rs/
Current Job Opportunities
EU Policy Officer - Junior Level
HEMOFARM AКCIONARSKO DRUŠTVO FARMACEUTSKO-HEMIJSKA INDUSTRIJA VRŠAC
juniorBrussels, BelgiumFull-time-time
Posted: 9/23/2025
mid-levelBrussels, Francefull-time
Posted: 8/21/2025